186 related articles for article (PubMed ID: 32818224)
1. A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma.
Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Hashimoto H; Takaeko Y; Harada T; Yamaji T; Han Y; Kihara Y; Chayama K; Goto C; Yusoff FM; Nakashima A; Higashi Y
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32818224
[TBL] [Abstract][Full Text] [Related]
2. Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.
Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Matsui S; Hashimoto H; Takaeko Y; Kihara Y; Chayama K; Goto C; Aibara Y; Yusoff FM; Nakashima A; Noma K; Liao JK; Higashi Y
J Hypertens; 2019 May; 37(5):1083-1095. PubMed ID: 30418321
[TBL] [Abstract][Full Text] [Related]
3. KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma.
Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Mizobuchi A; Harada T; Yamaji T; Hashimoto Y; Yoshimura K; Nakano Y; Goto C; Yusoff FM; Nakashima A; Higashi Y
Hypertens Res; 2023 Sep; 46(9):2213-2227. PubMed ID: 37463983
[TBL] [Abstract][Full Text] [Related]
4. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
Matsumoto T; Oki K; Kajikawa M; Nakashima A; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Hidaka T; Kihara Y; Kohno N; Chayama K; Goto C; Aibara Y; Noma K; Liao JK; Higashi Y
Hypertension; 2015 Apr; 65(4):841-8. PubMed ID: 25624340
[TBL] [Abstract][Full Text] [Related]
5. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.
Kishimoto S; Matsumoto T; Oki K; Maruhashi T; Kajikawa M; Matsui S; Hashimoto H; Kihara Y; Yusoff FM; Higashi Y
Hypertens Res; 2018 Nov; 41(11):932-938. PubMed ID: 30206323
[TBL] [Abstract][Full Text] [Related]
6. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
[TBL] [Abstract][Full Text] [Related]
7. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD;
Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research.
Chou CH; Chen YH; Hung CS; Chang YY; Tzeng YL; Wu XM; Wu VC; Tsai CT; Wu CK; Ho YL; Wu KD; Lin YH;
J Clin Endocrinol Metab; 2015 Nov; 100(11):4339-47. PubMed ID: 26401591
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
10. Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
Hung CS; Chou CH; Wu XM; Chang YY; Wu VC; Chen YH; Chang YS; Tsai YC; Su MJ; Ho YL; Chen MF; Wu KD; Lin YH;
J Hypertens; 2015 Sep; 33(9):1922-30; discussion 1930. PubMed ID: 26103125
[TBL] [Abstract][Full Text] [Related]
11. Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.
Wu CH; Yang YW; Hung SC; Tsai YC; Hu YH; Lin YH; Chu TS; Wu KD; Wu VC
Sci Rep; 2015 Oct; 5():15297. PubMed ID: 26477337
[TBL] [Abstract][Full Text] [Related]
12. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery.
Maruhashi T; Kajikawa M; Kishimoto S; Hashimoto H; Takaeko Y; Yamaji T; Harada T; Han Y; Aibara Y; Mohamad Yusoff F; Hidaka T; Kihara Y; Chayama K; Nakashima A; Goto C; Tomiyama H; Takase B; Kohro T; Suzuki T; Ishizu T; Ueda S; Yamazaki T; Furumoto T; Kario K; Inoue T; Koba S; Watanabe K; Takemoto Y; Hano T; Sata M; Ishibashi Y; Node K; Maemura K; Ohya Y; Furukawa T; Ito H; Ikeda H; Yamashina A; Higashi Y
J Am Heart Assoc; 2020 Jan; 9(2):e013915. PubMed ID: 31910779
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
[TBL] [Abstract][Full Text] [Related]
15. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction, abnormal vascular structure and lower urinary tract symptoms in men and women.
Matsui S; Kajikawa M; Maruhashi T; Iwamoto Y; Oda N; Kishimoto S; Hashimoto H; Hidaka T; Kihara Y; Chayama K; Hida E; Goto C; Aibara Y; Nakashima A; Yusoff FM; Noma K; Kuwahara Y; Matsubara A; Higashi Y
Int J Cardiol; 2018 Jun; 261():196-203. PubMed ID: 29657043
[TBL] [Abstract][Full Text] [Related]
17. Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma.
Park KS; Kim JH; Ku EJ; Hong AR; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Eur J Endocrinol; 2015 Jun; 172(6):725-31. PubMed ID: 25766046
[TBL] [Abstract][Full Text] [Related]
18. White blood cell count is not associated with flow-mediated vasodilation or nitroglycerine-induced vasodilation.
Kishimoto S; Maruhashi T; Kajikawa M; Harada T; Yamaji T; Han Y; Mizobuchi A; Hashimoto Y; Yoshimura K; Nakano Y; Chayama K; Goto C; Yusoff FM; Nakashima A; Higashi Y
Sci Rep; 2022 May; 12(1):8201. PubMed ID: 35581258
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.
Fujimura N; Noma K; Hata T; Soga J; Hidaka T; Idei N; Fujii Y; Mikami S; Maruhashi T; Iwamoto Y; Kihara Y; Chayama K; Kato H; Liao JK; Higashi Y;
Clin Pharmacol Ther; 2012 Feb; 91(2):289-97. PubMed ID: 22205191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
